Cytokines, breast cancer stem cells (BCSCs) and chemoresistance
Abstract Chemotherapy resistance of breast cancer poses a great challenge to the survival of patients. During breast cancer treatment, the development of intrinsic and acquired drug resistance tends to further induce adverse prognosis, such as metastasis. In recent years, the progress of research on...
Main Authors: | Weilong Chen, Yuanyuan Qin, Suling Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-09-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-018-0205-6 |
Similar Items
-
Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
by: Sònia Palomeras, et al.
Published: (2018-08-01) -
Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
by: Ajay Kumar Pal, et al.
Published: (2022-05-01) -
The Intricate Interplay between Cancer Stem Cells and Oncogenic miRNAs in Breast Cancer Progression and Metastasis
by: Antonis Tsintarakis, et al.
Published: (2023-06-01) -
Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development
by: Tianshu Zhang, et al.
Published: (2022-03-01) -
Cancer stem cell–immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet
by: Aishwarya Guha, et al.
Published: (2023-11-01)